Correlation Between Pfizer and AdvisorShares Pure
Can any of the company-specific risk be diversified away by investing in both Pfizer and AdvisorShares Pure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and AdvisorShares Pure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and AdvisorShares Pure Cannabis, you can compare the effects of market volatilities on Pfizer and AdvisorShares Pure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of AdvisorShares Pure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and AdvisorShares Pure.
Diversification Opportunities for Pfizer and AdvisorShares Pure
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Pfizer and AdvisorShares is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and AdvisorShares Pure Cannabis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AdvisorShares Pure and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with AdvisorShares Pure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AdvisorShares Pure has no effect on the direction of Pfizer i.e., Pfizer and AdvisorShares Pure go up and down completely randomly.
Pair Corralation between Pfizer and AdvisorShares Pure
Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.19 times more return on investment than AdvisorShares Pure. However, Pfizer Inc is 5.4 times less risky than AdvisorShares Pure. It trades about -0.22 of its potential returns per unit of risk. AdvisorShares Pure Cannabis is currently generating about -0.15 per unit of risk. If you would invest 2,802 in Pfizer Inc on August 30, 2024 and sell it today you would lose (219.00) from holding Pfizer Inc or give up 7.82% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. AdvisorShares Pure Cannabis
Performance |
| Timeline |
| Pfizer Inc |
| AdvisorShares Pure |
Pfizer and AdvisorShares Pure Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and AdvisorShares Pure
The main advantage of trading using opposite Pfizer and AdvisorShares Pure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, AdvisorShares Pure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AdvisorShares Pure will offset losses from the drop in AdvisorShares Pure's long position.| Pfizer vs. Emergent Biosolutions | Pfizer vs. Bausch Health Companies | Pfizer vs. Neurocrine Biosciences | Pfizer vs. Teva Pharma Industries |
| AdvisorShares Pure vs. AdvisorShares Pure Cannabis | AdvisorShares Pure vs. Trulieve Cannabis Corp | AdvisorShares Pure vs. Green Thumb Industries | AdvisorShares Pure vs. Amplify Seymour Cannabis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |